X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
α-interferon (1603) 1603
science & technology (1139) 1139
interferon (975) 975
life sciences & biomedicine (855) 855
humans (765) 765
infections (425) 425
female (412) 412
male (387) 387
cytokines (385) 385
viruses (377) 377
patients (363) 363
immunology (358) 358
gene expression (348) 348
proteins (325) 325
hepatitis (322) 322
medicine (302) 302
animals (296) 296
adult (284) 284
science & technology - other topics (283) 283
multidisciplinary sciences (281) 281
inflammation (277) 277
middle aged (276) 276
research article (274) 274
science (270) 270
immune system (254) 254
immune response (253) 253
lymphocytes t (244) 244
biological response modifiers (237) 237
γ-interferon (222) 222
hepatitis c (209) 209
interferon-alpha - therapeutic use (204) 204
lymphocytes (199) 199
health aspects (189) 189
oncology (174) 174
dendritic cells (171) 171
signal transduction (170) 170
antigens (168) 168
kinases (168) 168
mice (168) 168
infectious diseases (167) 167
virology (166) 166
viral infections (165) 165
tumor necrosis factor-α (164) 164
deoxyribonucleic acid--dna (160) 160
hepatitis c virus (158) 158
aged (151) 151
liver (149) 149
analysis (147) 147
ribonucleic acid--rna (146) 146
interleukin 6 (145) 145
microbiology (143) 143
ribavirin (139) 139
genes (137) 137
apoptosis (133) 133
medical research (127) 127
cell biology (126) 126
cancer (125) 125
flow cytometry (124) 124
leukocytes (123) 123
treatment outcome (118) 118
biology (116) 116
toll-like receptors (116) 116
pathogenesis (115) 115
studies (113) 113
tumors (113) 113
β-interferon (113) 113
therapy (111) 111
hepatitis b (109) 109
transcription (108) 108
chronic infection (107) 107
laboratories (107) 107
immunity (106) 106
interferon alpha (106) 106
clinical trials (104) 104
hematology (104) 104
research (104) 104
virus diseases (104) 104
biology and life sciences (102) 102
care and treatment (102) 102
phosphorylation (102) 102
antiviral agents - therapeutic use (101) 101
genomes (101) 101
polymerase chain reaction (101) 101
enzyme-linked immunosorbent assay (100) 100
liver diseases (100) 100
antiviral agents (97) 97
cell activation (96) 96
biochemistry & molecular biology (95) 95
interferon-alpha - pharmacology (95) 95
medicine and health sciences (95) 95
abridged index medicus (94) 94
rodents (94) 94
systemic lupus erythematosus (92) 92
interferon-alpha - administration & dosage (91) 91
animal models (90) 90
mutation (90) 90
vaccines (90) 90
human immunodeficiency virus--hiv (89) 89
immunotherapy (89) 89
tumor necrosis factor-tnf (89) 89
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1704) 1704
Japanese (68) 68
Chinese (32) 32
German (11) 11
Italian (10) 10
French (8) 8
Russian (5) 5
Korean (3) 3
Ukrainian (2) 2
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, pp. e0124463 - e0124463
Journal Article
Immunity (Cambridge, Mass.), ISSN 1074-7613, 04/2019, Volume 50, Issue 4, pp. 907 - 923
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2017, Volume 376, Issue 10, pp. 917 - 927
Journal Article
PloS one, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, pp. e0159019 - e0159019
[This corrects the article DOI: 10.1371/journal.pone.0156496.]. 
α-Interferon | Signaling | Interferon | USP18 protein
Journal Article
Leukemia, ISSN 1476-5551, 02/2018, Volume 32, Issue 5, pp. 1057 - 1069
Journal Article
The Journal of experimental medicine, ISSN 1540-9538, 05/2017, Volume 214, Issue 5, pp. 1547 - 1555
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2012, Volume 367, Issue 6, pp. 520 - 531
This international prospective study showed that maintenance therapy with rituximab was more effective than interferon alfa in prolonging the duration of... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Lymphoma, Mantle-Cell - mortality | Aged, 80 and over | Female | Maintenance Chemotherapy | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Survival Rate | Vidarabine - analogs & derivatives | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Vidarabine - administration & dosage | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Drugs | Dose-response relationship (Biochemistry) | Care and treatment | Fludarabine | Mantle cell lymphoma | Aged patients | Dosage and administration | Product/Service Evaluations | Drug therapy | Health aspects | Clinical trials | Prednisone | Lymphoma | Doxorubicin | Patients | Vincristine | α-Interferon | Cyclophosphamide | Motivation | Remission | Lymphomas | Computer centers | Age | Index Medicus | Abridged Index Medicus
Journal Article